[1] |
Waldmann TA, Steinfeld JL, Dutcher TF, et al. The role of the gastrointestinal system in "idiopathic hypoproteinemia"[J]. Gastroenterology, 1961, 41: 197-207.
pmid: 13782654
|
[2] |
Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease)[J]. Rev Med Interne, 2018, 39(7): 580-585.
doi: S0248-8663(17)30605-7
pmid: 28867533
|
[3] |
江载芳, 申昆玲, 沈颖. 诸福棠实用儿科学(第8版)[M]. 北京: 人民卫生出版社, 2015.
|
[4] |
Li S, Liu X, He Y, et al. Nutritional therapy and effect assessment of infants with primary intestinal lymphangiectasia: case reports[J]. Medicine (Baltimore), 2017, 96(51): e9240.
|
[5] |
Uğuralp S, Mutus M, Kutlu O, et al. Primary intestinal lymphangiectasia: a rare disease in the differential diagnosis of acute abdomen[J]. J Pediatr Gastroenterol Nutr, 2001, 33(4): 508-510.
|
[6] |
Fox U, Lucani G. Disorders of the intestinal mesenteric lymphatic system[J]. Lymphology, 1993, 26(2): 61-66.
pmid: 8355519
|
[7] |
Huber R, Semmler G, Mayr A, et al. Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature[J]. World J Gastroenterol, 2020, 26(48): 7707-7718.
|
[8] |
Vignes S, Carcelain G. Increased surface receptor Fas (CD95) levels on CD4+ lymphocytes in patients with primary intestinal lymphangiectasia[J]. Scand J Gastroenterol, 2009, 44(2): 252-256.
|
[9] |
Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults[J]. World J Gastrointest Oncol, 2011, 3(2): 19-23.
|
[10] |
柯文哲, 童冠圣, 刘勇, 等. 对比99Tcm-DX与99Tcm-HSA显像诊断小肠淋巴管扩张症[J]. 中国医学影像技术, 2014, 30(5): 772-775.
|
[11] |
Takahashi H, Imai K. What are the objectives of treatment for intestinal lymphangiectasia?[J]. J Gastroenterol, 2001, 36(2): 137-138.
pmid: 11227672
|
[12] |
Troskot R, Jurčić D, Bilić A, et al. How to treat an extensive form of primary intestinal lymphangiectasia?[J]. World J Gastroenterol, 2015, 21(23): 7320-7325.
|
[13] |
耿万德, 沈文彬, 孙宇光, 等. 小肠淋巴管扩张症15例的诊断和治疗[J]. 中华普通外科杂志, 2008, 23(5): 332-335.
|